NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Song, Ken [1 ]
机构：
[1] RayzeBio, San Diego, CA USA
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [42] DEVELOPMENT AND VALIDATION OF AN SCFV SPECIFIC FOR HUMAN GLYPICAN-3 FOR THERAPY OF HEPATOCELLULAR CARCINOMA
    Li, Yonghai
    Zhao, Aizhi
    Li, Hong
    Adeyemo, Oluwasayo
    Elkin, Daniel
    Scholler, Nathalie
    Kaplan, David E.
    HEPATOLOGY, 2009, 50 (04) : 1135A - 1135A
  • [43] Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma
    Nakatsura, T
    Nishimura, Y
    BIODRUGS, 2005, 19 (02) : 71 - 77
  • [44] Usefulness of the Novel Oncofetal Antigen Glypican-3 for Diagnosis of Hepatocellular Carcinoma and Melanoma
    Tetsuya Nakatsura
    Yasuharu Nishimura
    BioDrugs, 2005, 19 : 71 - 77
  • [45] Phase I Clinical Trial of Glypican-3 Peptide Vaccine in Patients with Hepatocellular Carcinoma
    Nakatsura, Tetsuya
    Yoshikawa, Toshiaki
    Kuronuma, Toshimitsu
    Shirakawa, Hirofumi
    Hayashi, Emiko
    Nishimura, Yoshiko
    Tsuchihara, Masami
    Motomura, Yutaka
    TUMOR BIOLOGY, 2008, 29 : 22 - 22
  • [46] Immunological efficacy of glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Shimomura, Manami
    Suzuki, Toshihiro
    Nosaka, Kazuto
    Shimizu, Hiroyasu
    Akazawa, Yu
    Charneau, Jimmy
    Sawada, Yu
    Endo, Itaru
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 276 - 276
  • [47] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
  • [48] A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA
    Wang, B.
    Ngoh, E.
    Soh, M. K.
    Yeap, Y.
    Huang, H.
    Tan, H. C.
    Hu, Y.
    Wang, C. I.
    HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
  • [49] Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
    Bell, Meghan M.
    Gutsche, Nicholas T.
    King, A. Paden
    Baidoo, Kwamena E.
    Kelada, Olivia J.
    Choyke, Peter L.
    Escorcia, Freddy E.
    MOLECULES, 2021, 26 (01):
  • [50] Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
    Kaseb, Ahmed Omar
    Hassan, Manal
    Lacin, Sahin
    Abdel-Wahab, Reham
    Amin, Hesham M.
    Shalaby, Ahmed
    Wolff, Robert A.
    Yao, James
    Rashid, Asif
    Vennapusa, Bharathi
    Feng, Janine
    Ohtomo, Toshihiko
    ONCOTARGET, 2016, 7 (43) : 69916 - 69926
12345